Engflag

Enat 400

Quick links to important sections

Enat 400

There is no image.

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Enat 400

Enat 400 is a preparation delivered as an oral softgel capsule that provides the body with the essential nutrient, D-alpha Tocopheryl Acetate (Vitamin E). It functions as a single-ingredient dietary supplement aimed at supporting overall cellular integrity.

Quick Facts

Property Description
Active ingredient D-alpha Tocopheryl Acetate (alpha-Tocopherol)
Form Oral Softgel Capsule
Pharmacological class Fat-Soluble Vitamin, Antioxidant
Common use Dietary supplementation, Oxidative stress protection
Origin Natural source (RRR stereoisomer)

What Type of Essential Nutrient is Enat 400?

Enat 400 belongs to the essential Pharmacological class of Fat-Soluble Vitamins and Antioxidants, supplying the body with the most active form of alpha-Tocopherol. As an essential nutrient, the body requires it for normal metabolic functions and cannot produce it internally, meaning it must be obtained through diet or supplementation. The supplement is typically positioned for adults seeking routine nutritional support, often where dietary intake of Vitamin E may be insufficient. The product's specific delivery as an oral softgel capsule in a lipid-based vehicle is designed for efficient absorption.

The Composition: Natural Origin of D-alpha Tocopheryl Acetate

The active compound in Enat 400 is D-alpha Tocopheryl Acetate, a stable and naturally sourced form of Vitamin E (RRR-alpha-Tocopheryl Acetate). This natural origin (D-alpha form) is a key differentiating factor, as it possesses the highest biological activity and utilization efficiency compared to synthetic variants. The acetate modification ensures the product's long-term stability against degradation until consumed, a specific compositional feature that guarantees the intended dose is delivered.

General Purpose: Function as a Biological Antioxidant

The fundamental general purpose of Enat 400 is linked to its established role as a potent chain-breaking antioxidant. This function is widely recognized in nutritional science. The alpha-Tocopherol works by embedding itself in the lipid layers of cell membranes, where it directly neutralizes unstable free radicals, thereby helping to prevent oxidative damage to cellular structures and supporting the maintenance of normal physiological processes throughout the body. A typical neutral use scenario for the product is supporting the maintenance of healthy skin and nerve tissues against routine environmental stressors.

Regulatory References

  1. Vitamin E - StatPearls - NIH
  2. Vitamin E | MedlinePlus

What side effects are possible with Enat 400?

Possible Side Effects and Safety Information

Official regulatory documentation classifies all specific adverse reactions associated with D-alpha Tocopheryl Acetate (Vitamin E) as Frequency Not Known, meaning their occurrence rate cannot be reliably estimated from available data. The documented side effects are typically associated with higher daily intake levels, often exceeding 700 mg (or approximately 1,045 IU) or 1,000 mg (1,490 IU).

Documented Non-Serious Adverse Reactions

Adverse effects listed in official safety documents are grouped by the System-Organ Class (SOC) they affect:

  • Gastrointestinal Disorders: May include nausea, diarrhea, abdominal pain, and intestinal cramps.
  • Nervous System Disorders: Effects such as headache and dizziness have been reported.
  • Other Systems: Blurred vision, rash, and general symptoms like unusual tiredness or weakness (asthenia) are also listed.

These effects are generally described as transient disturbances linked to the consumption of high doses.

Serious Safety Considerations and Constraints

The most significant safety considerations revolve around blood coagulation. High-dose and prolonged use may lead to an increased bleeding tendency and haemorrhage, resulting from Vitamin E's established antagonism with Vitamin K. There is also a documented risk of thrombosis (blood clot formation) in individuals predisposed to this condition, especially when taking oestrogens.

Regulatory authorities have set the Tolerable Upper Intake Level (UL) for supplemental alpha-tocopherol in adults at 1,000 mg per day (equivalent to 1,490 IU) based on the risk of increased tendency to haemorrhage.

Safety assessment is specifically required for individuals taking anticoagulants, those with bleeding disorders or mathbf Vitamin K deficiency, as well as for pregnant women, where the safety of high doses is not established.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented overdose profile for D-alpha Tocopheryl Acetate (Vitamin E) strictly based on government regulatory documentation.

Documented Manifestations and Severe Outcomes

High, chronic intake of Vitamin E is associated with both systemic manifestations and a serious hematological risk. Symptoms commonly documented in regulatory sources include gastrointestinal disturbances (nausea, diarrhea, abdominal pain, flatulence) and non-specific systemic effects like headache, fatigue, and muscle weakness.

The most critical severe outcome is an increased bleeding tendency and hemorrhage, resulting from the interference with Vitamin K coagulation factors. This risk is heightened for patients with a pre-existing Vitamin K deficiency or those receiving oral anticoagulants, a constraint explicitly noted in prescribing information.

Required Emergency Action

If an overdose is suspected or if severe symptoms, particularly any signs of bleeding, are observed, users must seek immediate medical attention or consult their physician immediately. The necessary initial step in management is the discontinuation of the supplement.

No specific antidote is known for general overexposure. Treatment is mandated to be symptomatic and supportive, although Vitamin K may be administered as a targeted intervention for active bleeding or clotting factor antagonism. Monitoring of coagulation factors (PT/INR) is required for high-risk patients during the observation period.

Therapeutic Uses of Enat 400

What Enat 400 Treats: Main Uses and Benefits

Enat 400 is commonly used to help with conditions presenting with systemic discomfort linked to Vitamin E deficiency. As a supportive measure, this supplement is relevant for easing symptoms related to systemic imbalance, cellular stress, and immune system strain. It is applied across domains where additional symptomatic support is needed, and contributes to easing the overall symptom load. It may assist with managing symptoms associated with tissue vulnerability and appearance, and is often used during phases when the body is under heightened systemic burden.

This use generally contributes to improved day-to-day comfort and stability during symptomatic periods. It may be part of symptomatic management to address symptoms related to tissue vulnerability and appearance.

Quick Fact: Support for Cellular Stress

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Enat 400? — Official Regulatory Information

The eligibility for using Enat 400 (D-alpha Tocopheryl Acetate) is defined by governmental regulatory authorities based on absolute prohibitions and conditional restrictions, primarily concerning age and pre-existing medical conditions.

Official Eligibility Profile

Classification Eligibility Rule (Regulatory Basis)
Absolute Contraindication Individuals with known hypersensitivity or allergy to alpha-Tocopherol or any excipient in the softgel capsule must not use this product.
Severe Restriction Use is strongly restricted or contraindicated in patients with uncontrolled bleeding disorders or hypoprothrombinemia (severe Vitamin K deficiency) due to the risk of exacerbating the condition.
Conditional Use Patients concurrently receiving anticoagulant treatments (e.g., Warfarin) require close medical monitoring due to the documented potential for increased bleeding risk.
Age Restriction The 400 IU adult-strength formulation is not recommended for infants or young children. Specific, much lower doses or formulations are required for pediatric populations.
Pregnancy/Lactation Use is generally acceptable at nutritional doses (RDA), but high doses exceeding the official Upper Intake Level (UL) are restricted and generally advised against by regulators.

Summary of Regulatory Eligibility:

Regulatory documentation establishes strict exclusion criteria for those with a documented allergy. It places a severe restriction on individuals with existing bleeding disorders. For the generally eligible adult population, use becomes conditional when concurrent anticoagulant medications are involved, necessitating medical oversight and monitoring. Furthermore, the 400 IU strength is formally considered unsuitable for use in young children, and high-dose use is restricted during pregnancy and lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns for D-alpha Tocopheryl Acetate (Vitamin E) based on regulatory information. Interactions are generally classified as requiring caution and monitoring rather than formal contraindication.

Pharmacodynamic and Absorption Interactions

Interacting Agent Category Official Interaction Pattern/Outcome
Oral Anti-Clotting Agents (e.g., Oral Anti-Vitamin K Agents, Antiplatelets) Co-administration may potentiate the effects of these medicines, increasing the risk of hemorrhage. This potential is linked to the anti-vitamin K activity of Vitamin E and is most relevant at high doses.
Fat Absorption Inhibitors (e.g., Orlistat) Interferes with the gastrointestinal absorption of D-alpha Tocopheryl Acetate, leading to reduced serum concentration of the vitamin.
Anticonvulsants / Oral Contraceptives Co-administration may result in lower plasma levels (reduced exposure) of the vitamin.
Oral Iron Salts (e.g., Ferrous Sulfate) Vitamin E may decrease the levels of these oral iron preparations due to inhibition of gastrointestinal absorption.

Administration Requirements

  • Orlistat: Regulatory labels specify that Orlistat must be taken two hours before or two hours after the administration of Vitamin E to mitigate the absorption interference.
  • Population Note: The potential interaction risk with oral anti-vitamin K agents is heightened in patients with existing Vitamin K deficiency.

This interaction structure reflects the need for special monitoring due to D-alpha Tocopheryl Acetate’s role as a fat-soluble vitamin and its documented influence on the blood clotting cascade, as defined by regulatory authorities.

Mechanism of Action

Core Mechanism: Arresting the Lipid Peroxidation Chain

Enat 400 (as alpha-Tocopherol) functions as a chain-terminating antioxidant by embedding itself directly into the lipid bilayers of cell membranes. This mechanism involves the molecule targeting and neutralizing highly destructive Lipid Peroxyl Radicals (ROO^bullet) through the donation of a hydrogen atom, which ceases the cascade of lipid peroxidation and modulates the oxidation of Polyunsaturated Fatty Acids (PUFAs). This action supports cellular structural integrity across systems rich in lipid bilayers, such as neural and vascular tissues.

Dependence on the Biological Redox Cycle

The molecule's mechanism involves its conversion into a less reactive radical form after its interaction. For the action to be sustained, this alpha-Tocopheroxyl radical must be efficiently regenerated back into its active state. This recycling process is dependent on the concurrent presence and function of other endogenous co-antioxidants, such as Vitamin C. This regeneration process provides for sustained activity of the molecule, supporting the continuation of the redox cycle. The activity is constrained by the molecule's fat-solubility, meaning its action is localized to hydrophobic (lipid-rich) environments, primarily the cell membrane.

Dosage and Administration Information

Administration Instructions

Enat 400 (D-Alpha Tocopheryl Acetate 400 I.U.) must be used strictly according to the official instructions provided in the product labeling or as directed by a healthcare professional. These instructions establish the specific conditions for safe and effective use.

Dosage and Frequency

The standard, officially recommended dose is one (1) capsule per day. The medicine is taken orally (by mouth). Unless otherwise advised by a physician for a specific treatment regimen, the recommended frequency is once daily.

Administration Conditions

Condition Instruction
Route Oral (by mouth)
Preparation Swallow the softgel capsule whole with liquid; do not crush or chew.
Timing with Meals Take the capsule with or after a meal.
Age Group Use is generally recommended for adults (18 years and above).

Missed Dose Management

If a dose is missed, patients should skip the forgotten dose and continue with their regular dosing schedule. It is specifically directed not to take a double or extra dose to make up for the missed one. Adhering to these procedural steps ensures the correct daily intake and prevents accidental overdosing.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Enat 400

Evidence for Use in Correcting Vitamin E Deficiency

Research has primarily examined Enat 400 (alpha-tocopherol) in clinical settings where individuals have a diagnosed Vitamin E deficiency. These studies typically involve administering the supplement and monitoring various outcomes related to systemic or functional imbalance, such as blood levels of alpha-tocopherol. The findings describe patterns observed in the studies where supplementation was observed to lead to measurable increases in blood Vitamin E levels and changes in deficiency-related laboratory markers. However, the results apply only to the populations studied (those with a confirmed deficiency), and research is ongoing to fully understand the effects outside of explicit deficiency states.

Evidence for Cardiovascular Event Outcomes

A significant amount of research, including large, long-term randomized controlled trials (RCTs), was studied for the potential relationship between alpha-tocopherol supplementation and outcomes related to major cardiovascular events like heart attacks and strokes. The findings were mixed across these large-scale studies. Some trials reported that the number of primary cardiovascular events was similar between the alpha-tocopherol group and the placebo group. Other studies described patterns where the measurements of certain biological markers were observed to be lower in the supplemented groups. Follow-up durations were limited in some reports, and the long-term effects are not fully established regarding the use of Enat 400 to specifically alter the risk of cardiovascular events across the general population.

What is Still Uncertain About Enat 400 Research

Despite the numerous trials, there is limited information for long-term outcomes regarding the habitual, prolonged use of Enat 400 in generally healthy populations. Evidence quality varies across studies due to differences in supplement formulation and varying baseline nutritional status of the participants. The findings were mixed across various indications, meaning the research has not yet provided a consistent picture of the measured effects across all areas that were studied for. This means research is ongoing to address these evidence gaps and to better contextualize the findings currently available in the broader evidence landscape.

Frequently Asked Questions (FAQ)

Common questions about Enat 400 (FAQ)

Q: What is Enat 400 typically used for?

A: Enat 400 is a form of Vitamin E, which is an essential nutrient and an antioxidant. It is commonly marketed as a dietary supplement. In certain instances, it may be prescribed to address documented Vitamin E deficiencies or related conditions, as determined by a healthcare provider.

Q: Does taking Enat 400 prevent heart disease?

A: Regulatory bodies and available clinical data do not support the claim that Vitamin E supplements prevent heart disease. While initial research suggested a potential benefit due to its antioxidant properties, large, long-term studies have generally not demonstrated a significant protective effect against cardiovascular events.

Q: Are there any known interactions with other medications?

A: Vitamin E supplements, especially at high doses like 400 IU, may interact with certain medications. This includes blood thinners (anticoagulants) due to a potential increase in bleeding risk. It may also affect how certain chemotherapy drugs work. It is crucial to inform your doctor or pharmacist about all supplements you take.

How should Enat 400 be stored and disposed of?

Storage and Disposal of Enat 400

Official regulatory guidelines for Enat 400 (D-alpha Tocopheryl Acetate soft capsules) detail specific conditions required to maintain the stability of the product.

Mandatory Storage Conditions

Storage must adhere to environmental controls that protect the fat-soluble vitamin. The product must be stored at temperatures not exceeding 30 C and requires mandatory protection from environmental factors such as light and moisture.

Condition Requirement
Temperature Not exceeding 30 C
Protection Protect from light and moisture
Safety Keep out of reach of children

Disposal Requirements

To ensure environmental safety, any unused or expired Enat 400 must be managed as pharmaceutical waste. Disposal must be conducted in accordance with local requirements and the product must not be emptied into drains, surface, or ground water.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Enat 400 found in:

A-Z Index: